PCRX

Pacira Biosciences Inc$25.35 1.02%
Health CareUSCUSIP 695127100· EOD Jul 20, 2026◍ Confluence graph
Tracked 13F Holders
173
-8 QoQ
13F Value (tracked)
$894.9M
Insider Net · 180d
-$1.4M
0↑ 5↓
Recent Filings
15
Smart-money sentimentBearish
BearishBullish
13F funds (latest Q)27 adding · 23 trimming
Insider net (180d)-$1.4M

Price & smart-money activity

$25.35 1.02%5Y -56.3%
$6.79$26.74$46.69$66.63$86.582021202220232024202520262602353762227242
Hover for who · click for detailEnd-of-day closing prices52w $19.16 – $27.22

Who owns PCRX?

173 tracked 13F filers

173 tracked 13F filers disclose a position in PCRX as of the latest SEC 13F filings, a combined $894.9M in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.

All quarters use one ordinary-share-equivalent series. Historical ADS are converted at 2 ADS = 1 ordinary share. Expand a row for the exact calculation; the residual is not classified as a trade.
#FundPosition valueSharesLast moveAs ofHistory
1BlackRock, Inc.
$152.2M
6.7M
−4.7%
Reduced · −329K sh
Q1 2026
2Doma Perpetual Capital Management LLC
$62.8M
2.8M
Held
Q1 2026
3VANGUARD PORTFOLIO MANAGEMENT LLC
$56.5M
2.5M
First observed position
No prior filed position
Q1 2026
4DIMENSIONAL FUND ADVISORS LP
$46.6M
2.1M
+5.7%
Added · +111K sh
Q1 2026
5D. E. Shaw & Co., Inc.
$44.8M
2.0M
−2.8%
Reduced · −57K sh
Q1 2026
6STATE STREET CORP
$43.4M
1.9M
+1.9%
Added · +36K sh
Q1 2026
7RENAISSANCE TECHNOLOGIES LLC
$41.3M
1.8M
−3.1%
Reduced · −59K sh
Q1 2026
8VANGUARD CAPITAL MANAGEMENT LLC
$40.3M
1.8M
First observed position
No prior filed position
Q1 2026
9GOLDMAN SACHS GROUP INC
$35.5M
1.6M
+21%
Added · +270K sh
Q1 2026
10MORGAN STANLEY
$31.5M
1.4M
+17%
Added · +200K sh
Q1 2026
11GEODE CAPITAL MANAGEMENT, LLC
$25.9M
1.1M
−2.2%
Reduced · −26K sh
Q1 2026
12AMERICAN CENTURY COMPANIES INC
$18.9M
838K
−37%
Reduced · −498K sh
Q1 2026
13CITADEL ADVISORS LLC
$18.0M
797K
−2.7%
Reduced · −22K sh
Q1 2026
14Impax Asset Management Group plc
$17.0M
750K
Held
Q1 2026
15CHARLES SCHWAB INVESTMENT MANAGEMENT INC
$16.5M
732K
+8.2%
Added · +56K sh
Q1 2026
16UBS Group AG
$12.7M
562K
+0.6%
Added · +3K sh
Q1 2026
17TWO SIGMA INVESTMENTS, LP
$11.9M
527K
+17%
Added · +75K sh
Q1 2026
18NORTHERN TRUST CORP
$11.7M
519K
−1.7%
Reduced · −9K sh
Q1 2026
19BRIDGEWAY CAPITAL MANAGEMENT, LLC
$9.3M
411K
−6.8%
Reduced · −30K sh
Q1 2026
20DEUTSCHE BANK AG\
$8.9M
392K
+1.1%
Added · +4K sh
Q1 2026
21Hillsdale Investment Management Inc.
$7.5M
331K
+7.5%
Added · +23K sh
Q1 2026
22Bank of New York Mellon Corp
$6.8M
303K
−8.2%
Reduced · −27K sh
Q1 2026
23FIRST TRUST ADVISORS LP
$6.8M
301K
+59%
Added · +112K sh
Q1 2026
24PRINCIPAL FINANCIAL GROUP INC
$6.4M
283K
+8.4%
Added · +22K sh
Q1 2026
25BARCLAYS PLC
$6.4M
282K
−19%
Reduced · −67K sh
Q1 2026

Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.

Is PCRX being bought or sold by institutions?

Last quarter, 2 funds opened a new position in PCRX and 25 added to an existing one, while 23 reduced and 0 exited entirely — based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).

Opened (NEW)
2
funds
Added
25
funds
Reduced
23
funds
Exited
0
funds

Funds that own PCRX also own

CompanyCo-held byCombined value
APPLE INCAAPL78 funds$44.1B
MICROSOFT CORPMSFT78 funds$39.7B
ELI LILLY & COLLY78 funds$9.5B
NVIDIA CORPNVDA77 funds$58.2B
AMAZON.COM INCAMZN77 funds$27.0B
SERVICENOW INCNOW77 funds$2.6B
BROADCOM INCAVGO76 funds$21.1B
TESLA INCTSLA76 funds$12.3B
JPMORGAN CHASE & COJPM76 funds$12.2B
BERKSHIRE HATHAWAY INC-CL BBRK/B76 funds$8.2B
MASTERCARD INC - AMA76 funds$6.1B
BOSTON SCIENTIFIC CORPBSX76 funds$2.2B

Ranked by how many of PCRX's institutional holders also hold each name, a cross-fund conviction signal.

Insider activity (Form 4)

Full insider page →
Buys · 180d
$0
0 insiders
Sells · 180d
$1.4M
5 insiders
Net
-$1.4M
10 P/S txns
Signal
Net Selling
open-market
DateInsiderRoleActionSharesValue
Jun 11, 2026RIKER LAURENSenior Vice President, FinanceSell (S)6K$144K
Jun 4, 2026WILLIAMS KRISTENChief Administrative OfficerSell (S)10K$228K
Apr 23, 2026Cross ShawnChief Financial OfficerSell (S)13K$326K
Apr 22, 2026Cross ShawnChief Financial OfficerSell (S)2K$38K
Apr 21, 2026Cross ShawnChief Financial OfficerSell (S)3K$71K
Apr 20, 2026Cross ShawnChief Financial OfficerSell (S)8K$194K
Mar 17, 2026Froimson MarkDirectorSell (S)500$11K
Mar 17, 2026SLONIN JONATHANChief Medical OfficerSell (S)3K$74K
Feb 2, 2026WILLIAMS KRISTENChief Administrative OfficerSell (S)13K$270K
Feb 2, 2026RIKER LAURENSenior Vice President, FinanceSell (S)4K$83K
Jan 5, 2026RIKER LAURENSenior Vice President, FinanceSell (S)1K$34K
Dec 10, 2025Cross ShawnChief Financial OfficerSell (S)9K$229K

Institutional ownership over time

173 funds+12 since Q3 2024
091181Q3 2024Q1 2025Q3 2025Q1 2026
funds holding aggregate valuelatest $890.0M

Recent filings

15 shown

Browse more

Build

Ask your agent what changed in PCRX

This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/stocks/PCRX/capital-change-brief"
Ask your agent
Use Arkolith's capital_change_brief for PCRX.
Tell me what changed, whether insider activity
corroborates it, and cite the SEC evidence.

13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for PCRX. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.